Value of elastin staining in the assessment of peritoneal implants associated with ovarian serous borderline tumours

Histopathology

Volumn 51, Issue 3, 2007, Pages 313-321

  Stewart, C J R ^a   Brennan, B A ^a   Crook, M L ^a   Russell, P ^b  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Elastin; Ovary; Peritoneal implant; Serous borderline tumour

Indexed keywords

ELASTIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE PROCEDURE; LAMINA PROPRIA; NON INVASIVE PROCEDURE; OMENTUM; OVARY TUMOR; PERITONEAL BIOPSY; PERITONEUM; PRIORITY JOURNAL; STAINING;

ADULT; AGED; AGED, 80 AND OVER; CYSTADENOCARCINOMA, SEROUS; ELASTIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PERITONEUM; PREDICTIVE VALUE OF TESTS;

EID: 34548136155     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02789.x     Document Type: Article

References (28)

1. Acs G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am. J. Clin. Pathol. 2005 123 (Suppl. 1 S13 57.
2. Hart WR. Borderline epithelial tumors of the ovary. Mod. Pathol. 2005 18 S33 50.
3. Bell DA, Weinstock MA, Scully RE. Peritoneal implants of ovarian serous borderline tumors: histologic features and prognosis. Cancer 1988 62 2212 2222.
4. Silva EG, Gershenson DM, Malpica A, Deavers M. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Am. J. Surg. Pathol. 2006 30 1367 1371.
5. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types: a clinicopathologic study of 65 advanced stage cases. Am. J. Surg. Pathol. 1996 20 1331 1345.
6. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am. J. Surg. Pathol. 1996 20 1319 1330.
7. Eichhorn JH, Bell DA, Young RH, Scully RE. Ovarian serous borderline tumors with micropapillary and cribriform patterns. A study of 40 cases and comparison with 44 cases without these patterns. Am. J. Surg. Pathol. 1999 32 397 409.
8. Smith Sehdev AE, Sehdev PS, Kurman RJ. Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary. A clinicopathologic analysis of 135 cases. Am. J. Surg. Pathol. 2003 27 725 736.
9. Slomovitz BM, Caputo TA, Gretz HF et al. A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component. Am. J. Surg. Pathol. 2002 26 592 600.
10. Gilks CB, Alkushi A, Yue JJW et al. Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases. Int. J. Gynaecol. Pathol. 2002 22 29 36.
11. Deavers MT, Gershenson DM, Tortolero-Luna G et al. Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential. A study of 99 advanced-stage cases. Am. J. Surg. Pathol. 2002 26 1129 1141.
12. Prat J, de Nictolis M. Serous borderline tumors of the ovary. A long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am. J. Surg. Pathol. 2002 26 1111 1128.
13. Bell DA, Scully RE. Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum. Pathol. 1990 21 397 403.
14. Kennedy AW, Hart WR. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors): a long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Am. J. Surg. Pathol. 1996 78 278 286.
15. McKenney JK, Balzer BL, Longacre TA. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion. Am. J. Surg. Pathol. 2006 30 1209 1221.
16. Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum. Pathol. 2000 31 539 557.
17. Morice P, Camatte S, Rey A et al. Prognostic factors for patients with advanced stage serous borderline tumours of the ovary. Ann. Oncol. 2003 14 592 598.
18. Longacre TA, McKenney JK, Tazelaar HD, Kempson RL, Hendrickson MR. Ovarian serous tumors of low malignant potential (borderline tumors). Outcome-based study of 276 patients with long-term (> 5-year) follow up. Am. J. Surg. Pathol. 2005 29 707 723.
19. Kurman RJ, Seidman JD, Shih I-M. Serous borderline tumours of the ovary. Histopathology 2005 47 310 315.
20. Longacre TA, Kempson RL, Hendrickson MR. Serous tumours of low malignant potential (serous borderline tumours): moving toward détente. Histopathology 2005 47 315 318.
21. Knudsen PJ. The peritoneal elastic lamina. J. Anat. 1991 177 41 46.
22. Shinto E, Ueno H, Hashiguchi Y et al. The subserosal elastic lamina: an anatomic landmark for stratifying pT3 colorectal cancer. Dis. Colon Rectum 2004 47 467 473.
23. Stewart CJR, Hillery S, Havlat M. Serosal involvement in colorectal carcinoma. Histopathology 2006 49 435 437.
24. Butnor KJ, Cooper K. Visceral pleural invasion in lung cancer. Recognising histologic parameters that impact staging and prognosis. Adv. Anat. Pathol. 2005 12 1 6.
25. Bell KA, Smith Sehdev AE, Kurman RJ. Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas. Am. J. Surg. Pathol. 2001 25 419 432.
26. Gershenson DM, Silva EG. Serous ovarian tumors of low malignant potential with peritoneal implants. Cancer 1990 65 578 585.
27. Gershenson DM, Silva EG, Levy L, Burke TW, Wolf JK, Tornos C. Ovarian serous borderline tumors with invasive peritoneal implants. Cancer 1998 82 1096 1103.
28. Lee ES, Leong AS-Y, Kim Y-S et al. Calretinin, CD34, and α-smooth muscle actin in the identification of peritoneal invasive implants of serous borderline tumors of the ovary. Mod. Pathol. 2006 19 364 372.